Virginia Ruth Sanzone - 06 Mar 2022 Form 4 Insider Report for ICU MEDICAL INC/DE (ICUI)

Role
VP, General Counsel
Signature
By: Paula Darbyshire, Attorney-in-fact For: Virginia Sanzone
Issuer symbol
ICUI
Transactions as of
06 Mar 2022
Net transactions value
-$388,445
Form type
4
Filing time
08 Mar 2022, 18:19:44 UTC
Previous filing
13 Sep 2021
Next filing
12 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ICUI Common Stock Options Exercise $0 +1,444 +90% $0.000000 3,049 06 Mar 2022 Direct F1
transaction ICUI Common Stock Tax liability $184,627 -760 -25% $242.93 2,289 06 Mar 2022 Direct
transaction ICUI Common Stock Options Exercise $0 +1,595 +70% $0.000000 3,884 06 Mar 2022 Direct F1
transaction ICUI Common Stock Tax liability $203,818 -839 -22% $242.93 3,045 06 Mar 2022 Direct
transaction ICUI Common Stock Options Exercise $0 +2,272 +75% $0.000000 5,317 08 Mar 2022 Direct F1
transaction ICUI Common Stock Tax liability $0 -1,196 -22% $0.000000 4,121 08 Mar 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ICUI Common Stock Award $0 +3,218 $0.000000 3,218 07 Mar 2022 Common Stock 3,218 $0.000000 Direct F2, F3, F4, F5
transaction ICUI Performance Shares Options Exercise $0 -2,272 -33% $0.000000 4,545 08 Mar 2022 Common Stock 2,272 $0.000000 Direct F1, F6, F7
transaction ICUI Performance Shares Options Exercise $0 -1,444 -100% $0.000000* 0 06 Mar 2022 Common Stock 1,444 Direct F1, F6, F8
transaction ICUI Performance Shares Options Exercise $0 -1,595 -50% $0.000000 1,595 06 Mar 2022 Common Stock 1,595 Direct F1, F6, F9
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These Securities are Performance-based Restricted Stock Units (PRSU).
F2 These securities are Restricted Stock Units.
F3 There is neither a purchase price nor an exercise price for the Restricted Stock Units.
F4 One third of the units subject to the award shall vest on each of the first, second, and third anniversaries of the grant date.
F5 These are restricted stock units that fully vest 3 years from the grant date.
F6 There is neither a purchase price nor an exercise price for the PRSUs.
F7 These PRSUs were granted on March 6, 2021. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.
F8 These PRSUs were granted on March 6, 2019. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.
F9 These PRSUs were granted on March 6, 2020. Vesting of these performance stock units are subject to the satisfaction of both performance-based conditions and time-based criteria. These PRSUs vest on March 6 of the first, second, and third year following the year of grant.